The liver is the central organ that responds to dietary cholesterol intake and facilitates the release and clearance of lipoprotein particles. Persistent hypercholesterolemia leads to immune responses against lipoprotein particles that drive atherosclerosis. However, the effect of hypercholesterolemia on hepatic T-cell differentiation remains unknown.
A therosclerosis is a chronic inflammatory disease induced when cholesterol-containing plasma lipoproteins accumulate in the arterial wall. These lipoproteins, including very low-density lipoprotein and low-density lipoprotein (LDL), are formed in the liver, circulate throughout the vasculature, and are cleared from the blood by lipoprotein receptors in the liver. Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease, and lipid-lowering represents a successful strategy for disease prevention.
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The liver is a unique immunological site and hepatic tolerance induction against ectopic antigens has been shown to inhibit autoimmune responses systemically. 1 Hepatic tolerance is implemented by regulatory T (Treg) cell induction through transforming growth factor-β1 (TGF-β1) secretion in situ. 2 The immunological homeostasis in the liver is particularly important in the context of atherosclerosis, as subacute hepatic inflammation aggravates lesion development, 3 whereas disruption of inflammatory signaling pathways in hepatocytes alleviates atherosclerosis. 4 However, the intrahepatic T-cell differentiation in hypercholesterolemia and its contribution to atherosclerosis has not been investigated so far.
The development of atherosclerotic lesions in the arterial wall is linked to the presence of proatherogenic CD4 + T cells as well as macrophages. Hence, impairment of T-cell homeostasis aggravates atherosclerosis, whereas inhibition of T-cell immunity abrogates the disease. 5 A crucial role to suppress inflammatory processes and to sustain immune tolerance is played by CD4 + Treg cells that either originate from the thymus or differentiate in the periphery in response to TGF-β. 6, 7 Treg cells express the lineage-defining transcription factor FoxP3 and suppress atherosclerosis. [8] [9] [10] On the contrary, disease development is aggravated by specific proinflammatory CD4 + T cells recognizing the protein component of LDL, apolipoprotein B-100, that is expressed in the liver. 11, 12 To elucidate the effect of plasma cholesterol concentrations on T-cell differentiation, we treated mice for different time periods with cholesterol-containing diets and used LDL receptor knockout (Ldlr −/− ) mice that develop severe, diet-induced hypercholesterolemia. Subsequently, we characterized phenotype and function of differentiated T-cell subsets in the liver and assessed their migration into the artery wall by transfer experiments and relocation assays.
Our data show that dietary-induced hypercholesterolemia increases CD4 + Th17 cell populations specifically in the liver in a process that parallels the induction of TGF-β1 expression in this organ. Intrahepatically differentiated Treg cells migrated to the aorta in adoptive transfer experiments, suggesting that they may modulate disease development through atheroprotective activity. Intrahepatic Treg differentiation was hampered under conditions when severe hypercholesterolemia caused liver inflammation, in which case differentiation of proatherogenic Th1 cells was promoted. We conclude that liver lipid levels are important regulators of immune inflammation and atherosclerosis.
Methods

Animals
Experiments have been carried out on in-house bred transgenic or nontransgenic hemizygous DEREG FoxP3 reporter mice on a C57BL/6J background, kindly provided by Dr T. Sparwasser (Institute for Infection Immunology, TWINCORE, Hannover, Germany) and in-house bred Ldlr −/− mice (The Jackson Laboratory), as previously described. 8 For some experiments, cross-bred DEREGxLdlr −/− mice were used. All experimental animals were bred under standard housing conditions, were between 8 and 10 weeks of age, were genotyped, and were randomly selected into treatment groups. Mice were fed cholesterol-free standard chow diet (SCD; R70, Lantmännen, Sweden), 0.15% cholesterol-containing Western diet (WD; R638, Lantmännen, Sweden), or 1.125% cholesterol-containing WD (D12108C, Research Diets) for indicated time periods; detailed list of ingredients is provided in (Online Table I ).
Statistics
Values are expressed as mean±SEM. Nonparametric MannWhitney U test or parametric Student t test was used for comparisons between 2 groups as indicated. Correlations were calculated using Spearman rank test. One-and 2-way ANOVA followed by Bonferroni multiple comparison post hoc test was performed for comparisons of more than 2 groups. D'Agostino and Pearson omnibus normality test was performed to assess normal distribution of data sets. Differences were considered significant at P values <0.05 (2-tailed). All statistical analyses were performed using GraphPad Prism software.
A detailed description of additional standard methods, online figures, and figure legends is provided in the Online Supplement.
Results
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We analyzed the murine intrahepatic CD4 + T-cell compartment and observed that the liver harbors a phenotypically distinct population of FoxP3 + Treg cells that mostly lack CD25 expression compared with Treg cells from spleen ( Figure  1A) . Surprisingly, cholesterol-containing WD treatment for 4 weeks increased this intrahepatic Treg cell population compared with control mice receiving cholesterol-free SCD ( Figure 1B and 1C 
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Novelty and Significance
What Is Known?
• Anti-inflammatory regulatory T (Treg) cells and proinflammatory T-helper (Th) cell subsets affect the development of atherosclerosis.
• Severe hypercholesterolemia and liver inflammation aggravate atherosclerosis.
• However, the contribution of hypercholesterolemia-mediated differentiation of T-cell subsets in the liver to atherosclerosis is unknown.
What New Information Does This Article Contribute?
• Liver inflammation is a risk factor for cardiovascular disease and the recognition of liver-derived antigens by proatherogenic T cells exacerbates atherosclerosis. However, the intrahepatic T-cell response in hypercholesterolemia has not been investigated. We found that dietary cholesterol intake increases the expression of transforming growth factor-β1 and induces the differentiation of Treg and Th17 cells in the liver of wild-type mice, whereas hepatocyte damage, CD11b + CD11c + leukocyte accumulation, and Th1 cell differentiation occur in the liver of severely hypercholesterolemic Ldlr −/− mice. Adoptive T-cell transfer experiments demonstrate that hypercholesterolemia increases the migration of hepatic Treg cells into the atherosclerotic aorta of recipient Ldlr −/− mice. This work shows that hepatic T cells differentiate in response to hypercholesterolemia and indicates their contribution to the T-cell pool in the atherosclerotic aorta. These findings light on the link between chronic liver diseases, such as hepatitis and nonalcoholic fatty liver disease, and cardiovascular disease.
of the intrahepatic CD4 + T-cell population was not due to the loss of CD4 + NKT cells (Online Figure ID) . These results were also confirmed in FoxP3 reporter mice (DEREG), in which fully functional CD4 + FoxP3 + Treg cells are readily detectible through their green fluorescent protein expression. 
Correlation Between Hypercholesterolemia and Intrahepatic Treg Cells
On the basis of our findings, we hypothesized that hypercholesterolemia may affect the residential Treg cell population in liver. To test this, we fed wild-type mice WD with different cholesterol contents and subsequently analyzed intrahepatic Treg cells. As expected, plasma cholesterol concentrations were significantly elevated in mice treated for 4 weeks with 0.15% and 1.125% cholesterol-enriched WD, respectively (Online Figure IIB) . In response to higher dietary cholesterol intake, the percentage of FoxP3-expressing cells among CD4 + T cells increased, as did their proliferation (Figure 2A ). To further strengthen our hypothesis that systemic hypercholesterolemia influences the intrahepatic Treg cell population,
Ldlr
−/− mice were fed SCD or WD to provoke even higher plasma cholesterol levels. This led to significantly expanded Treg cell populations among intrahepatic CD4 + T cells ( Figure 2B ). Moreover, LDLr deficiency in DEREG mice significantly increased the intrahepatic Treg cell population and decreased their CD62L expression upon WD treatment, indicating an expansion of the FoxP3 + effector cell population ( Figure 2C ). The intrahepatic Treg cell population correlated linearly with hypercholesterolemia in Ldlr +/+ and Ldlr −/− mice ( Figure 2D and 2E) . Together, this data support the notion that dietary-induced hypercholesterolemia, rather than other WD ingredients, affects the intrahepatic Treg cell population size.
The unique ability of FoxP3 to imprint the Treg cell phenotype and function has been demonstrated by retroviral transduction experiments. 15 Several post-transcriptional and post-translational control mechanisms regulate the function of FoxP3. 16, 17 To eliminate the possibility that these modifications interfered with the detection of FoxP3, we used different antibody clones for intracellular flow cytometry, analyzed liver cell lysates in immunoblots and quantified alternatively spliced transcripts of FoxP3 mRNA. We observed homogenous FoxP3 detection by both antibodies in liver obtained from SCD and WD fed wild-type mice, a single FoxP3 protein band with higher intensity in Ldlr −/− than Ldlr +/+ liver of WD fed mice and a conserved ratio of exons in the untranslated region of FoxP3 transcripts (Online Figure IIIA through IIIC). This validates our analytic approach and strongly suggests that hypercholesterolemia induces FoxP3 expression in intrahepatic T cells without changing isoforms, inducing post-translational modifications or causing alterations of the transcription start site.
WD Increases Hepatic TGF-β1 Expression and TGF-β1-Related Phenotypic Changes of Intrahepatic T Cells
The low expression of CD25, the conversion to CD62L Helios, also Neuropilin-1 (Nrp-1) was suggested to characterize thymic Treg cells. 18 However, Nrp-1 was stably expressed by intrahepatic Treg cells and by a subset of proliferating and Ldlr −/− mice (Online Figure IVB) . Because Nrp-1 is induced by and acts as receptor for TGF-β1, 19, 20 we reasoned that the increase of liver-resident Treg cells and the expression of Nrp-1 by proliferating liver-resident non-Treg cells may be mediated through local TGF-β1 production. Thus, we measured TGF-β1 plasma concentrations and quantified TGF-β1 mRNA in liver from SCD or WD fed mice. TGF-β1 concentrations correlated linearly with cholesterol concentrations in plasma ( Figure 3A) . Furthermore, TGF-β1 mRNA levels in the liver were significantly higher in WD compared Representative flow cytometry data out of 2 independent experiments are shown; values are expressed as mean±SEM; 2-tailed Mann-Whitney U test was performed for statistical analysis; **P<0.01; r=Spearman rank correlation coefficient; white, gray, and black color indicates 0%, 0.15% and 1.125% cholesterol diet, respectively.
with SCD fed mice and correlated linearly with the intrahepatic Treg cell compartment ( Figure 3B ; Online Figure IVC) . Next, we analyzed hypercholesterolemia-induced TGF-β1 expression in liver cells by flow cytometry of the TGF-β1 propeptide, latency-associated peptide. Intracellular staining for latency-associated peptide revealed that liver cells derived from WD fed mice expressed significantly higher levels of latency-associated peptide compared with SCD fed littermates ( Figure 3C ). The analysis of different liver cell types showed that WD promoted latency-associated peptide expression in CD31+ liver subpopulations and moderately in CD4 + lymphocytes, but not in glial fibrillary acidic protein (GFAP + ) liver cells ( Figure 3D ). To exclude the possibility that hypercholesterolemia also directly affects FoxP3 expression in lymphocytes, purified CD4 + T cells were cultured in the presence or absence of LDL particles. We found that the addition of LDL or oxidized LDL in vitro had no effect on FoxP3 expression in CD4 + T-cell cultures, alone or in combination with TGF-β1, indicating that hypercholesterolemia affects iTreg cell differentiation indirectly via local TGF-β1 induction rather than through an intrinsic CD4 + T-cell mechanism (Online Figure V and data not shown). Taken together, these findings demonstrate that hypercholesterolemia promotes hepatic TGF-β1 expression that is associated with increased intrahepatic iTreg cell differentiation.
Hypercholesterolemia Inhibits T-Cell Proliferation in the Liver
To assess whether hypercholesterolemia-mediated TGF-β1 induction and iTreg cell generation in the liver inhibits T-cell responses, we determined the tissue-specific capacity to support the proliferation of adoptively transferred T cells in SCD and WD fed wild-type mice. For this, CellTrackerlabeled CD4 + T cells were incubated short-term with mitogenic anti-CD3 antibodies in vitro and their subsequent in vivo proliferation was assessed in liver and spleen. In both organs about 0.3% of the local T-cell population came from the adoptive transfer. Transferred T cells that entered the liver of WD fed mice were significantly inhibited in their proliferation compared with transferred cells entering the liver of SCD fed mice (Figure 4) . In contrast, no differences were observed for the proliferation of transferred cells retrieved from the spleen of SCD or WD fed mice. This indicates that dietary-induced hypercholesterolemia leads to immunosuppressive conditions specifically in the liver and suggests that intrahepatic TGF-β1 and iTreg cells affect the proliferation of T cells in situ. Figure 5B, right) . In particular, the effect of hypercholesterolemia on T-cell differentiation profiles was specific for intrahepatic T cells because no changes were detected for in vivo differentiated Th17 cells (about 1%) or Th1 cells (about 12%) in the spleen (Online Figure VIB) .
Hypercholesterolemia Affects the Differentiation of
To further validate that dietary cholesterol intake or the Ldlr genotype correlates with intrahepatic T-cell differentiation we performed real-time polymerase chain reaction analysis of whole liver lysates and hepatic leukocytes. Corroborating our flow cytometry data, WD significantly increased TGF-β1 mRNA levels in both fractions and FoxP3 as well as ROR-γt mRNA levels in hepatic leukocytes, whereas mRNA concentrations of IL-6 correlated with the Ldlr genotype in whole liver lysates but did not reach statistical significance in hepatic leukocyte fractions (Online Figure VIIA and VIIB) . In contrast to diet-dependent Treg/Th17 cell-related genes, the significant increase of IL-12a mRNA concentration in whole liver lysate and IFN-γ mRNA concentration in hepatic leukocytes was associated with the Ldlr genotype, whereas Th2-related Gata-3 was unaffected by both, diet and Ldlr genotype (Online Figure VIIIA and Figure IX) . These changes coincided with an increased release of alanine transaminase into the plasma of WD fed Ldlr −/− mice, reflecting hepatocyte damage, whereas the liver of wild-type mice was unaffected (Online Figure X) . In summary, these results suggest that hypercholesterolemia-induced TGF-β1 expression in the liver promotes iTreg and Th17 cell differentiation in Ldlr +/+ mice. In contrast, severe hypercholesterolemia in Ldlr −/− mice elicits hepatocyte damage and facilitates additional costimulatory signals by accumulating + T cells were prestimulated in vitro with anti-CD3 and transferred intravenously into wild-type mice that were fed cholesterol-free standard chow diet (SCD) or 0.15% cholesterol-containing Western diet (WD) for 4 wk (n=5). In vivo proliferation of transferred cells in liver (top) and spleen (bottom) of SCD (black) or WD (gray) fed mice was measured through dye dilution after 4 days (undivided and proliferating cells indicated by dashed and solid lines, respectively) and relative proliferation was calculated (mean proliferation SCD=100%). Representative flow cytometry data out of 2 independent experiments are shown; values are expressed as mean±SEM; 2-tailed Mann-Whitney U test was performed for statistical analysis; *P<0.05.
CD11b
+ CD11c + cells in the liver, which specifically restricts Th17 cell differentiation but triggers Th1 cell differentiation instead.
Relocation of Intrahepatically Differentiated T Cells
Because hypercholesterolemia induced differential T-cell subsets in liver, but not in spleen, we sought to assess the contribution of these T cells in atherosclerosis. transfer, the intrahepatically differentiated and labeled cells were retrieved from different tissues and their ability to remigrate to the liver or to relocate to the spleen and aorta was assessed. We observed that in absolute numbers, transferred cells were partly remigrating to the liver but mostly relocated to the spleen ( Figure 7A ). The expression analysis for transcription factors of retrieved cells showed that hypercholesterolemiainduced hepatic FoxP3 + Treg cells were not remigrating into the liver but rather relocated to the spleen ( Figure 7B ). In both organs, transferred T cells did not maintain their hypercholesterolemia-induced ROR-γt profile (Online Figure XIA and  XIB) . In addition, in vitro restimulation of transferred T cells retrieved from liver and spleen demonstrated that liver-derived 
Transferred Intrahepatically Differentiated T Cells Enter the Atherosclerotic Aorta
To assess homing of liver T cells to the atherosclerotic vasculature, we analyzed aortas of recipient Ldlr −/− mice by flow cytometry. Besides the residential CD4 + T-cell population infiltrating the aortic wall during atherosclerotic lesion development, some cells originating from the transferred hepatic
CD4
+ T cells could be identified ( Figure 7C ). Interestingly, these intrahepatically differentiated cells were relatively abundant in the aorta, where they showed a median value of 0.665% of all CD4 + T cells (minimum: 0.08%, maximum: 18.5%). In contrast, the transferred cells were strongly outcompeted by residential CD4 + T cells in liver, spleen, and paraaortic lymph nodes, with median values of 0.027% (minimum: 0.002%, maximum: 0.180%), 0.014% (minimum: 0.001%, maximum: 0.051%), and 0.015% (minimum: 0.004%, maximum: 0.061%), respectively. This shows that hepatic T cells have access to other tissues and particularly contribute to the CD4 + T-cell pool in the atherosclerotic aorta, where liver-derived antigens, such as apolipoprotein B-100, are abundant.
Next, we investigated whether dietary treatment or Ldlr genotype of the transferred hepatic T cells affected their migration into the atherosclerotic aorta. For this, the density of cells relocating to target organs was normalized with the density of cells remigrating to the liver to compensate for unintentional variations in transferred CD4 + T-cell numbers. Hepatic CD4 + T cells originating from WD fed mice preferentially appeared in the aorta and in the spleen ( Figure 7D ; Online Figure XID) . Moreover, hepatic CD4 + T cells that relocated to the atherosclerotic aorta expressed significantly more FoxP3 and ROR-γt than the residential CD4 + T-cell population ( Figure 7E) . Thus, intrahepatically differentiated Treg cells can infiltrate the inflamed aorta, where they may conceivably affect the inflammatory process in the developing atherosclerotic lesion.
Discussion
In this study, we show that (1) hypercholesterolemia increased the differentiation of intrahepatic iTreg and Th17 cells, whereas (2) the disruption of liver homeostasis elicits Th1 cells. (3) Induction of iTreg and Th17 cells was associated with increasing levels of TGF-β1, suggesting that this growth factor accounted for the process. Finally, (4) T cells differentiated in the hypercholesterolemic liver entered the atherosclerotic aorta, suggesting that hypercholesterolemia-induced intrahepatic T-cell subsets can affect immune responses against liverderived antigens in atherosclerosis.
Besides their role in host defense against pathogens, immune cells can also modulate lipid metabolism. 21 Strikingly, Treg cells have been shown to inhibit atherosclerosis not only through the suppression of adaptive immune responses but also by ameliorating the atherogenic lipoprotein profile in Ldlr −/− mice. 8, 9 Here, we found a linear relationship between intrahepatic Treg cell populations and plasma cholesterol concentrations. In this context, the increased differentiation and expansion of intrahepatic Treg cells seems to be a safe-guard mechanism to avoid disease development in hypercholesterolemia. This implies that elevated physiological plasma cholesterol levels could promote the induction of hepatic tolerance to liver-derived antigens, which may contribute to prevent atherosclerosis. In line with this, previous studies demonstrated that subliminal and tolerogenic immunization protocols facilitate a reduction in experimental atherosclerosis. 22 24 In contrast, the mouse liver harbors a FoxP3 + Treg cell population that mostly lacks CD25 expression and does not exceed 50 000 cells per organ. To evaluate the suppressive capacity of this subpopulation is challenging, since the low expression of the IL-2 receptor α-chain implies that these cells have an impaired ability to compete for IL-2 in in vitro assays. 25 Therefore, we directly measured the proliferation of prestimulated responder cells in vivo to assess whether hypercholesterolemia-induced intrahepatic changes suppress cellular immune responses. By this, we found that the integral condition, specified by hepatic TGF-β1, iTreg cells, and APC maturation, inhibited the proliferation of T cells specifically in the liver of WD fed mice. Thus, hypercholesterolemia-induced iTreg cells are likely to partake in the suppression of hepatic T-cell proliferation. This property should make hepatic iTreg cells interesting targets in future vaccination strategies against atherosclerosis.
TGF-β1 is known to exert atherosclerosis-protective effects. [26] [27] [28] [29] [30] [31] Here, we show that TGF-β1 expression increased in the liver upon dietary-induced hypercholesterolemia. This is in line with previous studies demonstrating that hypercholesterolemia increases TGF-β1 in the plasma of atherosclerotic mice and that TGF-β1 signaling in CD4 + T cells strongly inhibits disease. 31, 32 In the periphery, TGF-β1 mediates the differentiation of iTreg cells in the absence of proinflammatory cytokines, whereas the presence of proinflammatory cytokines favors the differentiation of Th17 cells. This iTreg/Th17 cell balance seems to define the outcome of many chronic inflammatory diseases, including atherosclerosis. 33, 34 However, the priming site of differentiating T cells in atherosclerosis has been unknown so far. Here we report that intrahepatic, but not intrasplenic, T cells responded toward atherosclerosis-prone conditions, highlighting the unique role of the liver in disease development. The liver expresses autoantigens implicated in atherogenesis, such as apolipoprotein B-100, and offers the first opportunity for potentially autoreactive T cells to encounter antigen-loaded APCs in the periphery. Hepatocytes and nonhepatocytes, such as GFAP + hepatic stellate cells, Kupffer cells, and CD31
+ liver sinusoidal endothelial cells, have been reported to synthesize or store TGF-β1. [35] [36] [37] Expression of this cytokine in the liver has been related to hepatitis, fibrosis, liver regeneration, and carcinogenesis. [38] [39] [40] [41] Our current data show that hypercholesterolemia increased the TGF-β1 concentration in the liver and this was associated with increased intrahepatic iTreg/Th17 cell populations. However, causality is difficult to prove considering that the pleiotropic functions and the heterogeneous origin of the cytokine, as well as its complicated kinetics, do not allow neutralization or conditional knockout strategies.
Notably, we observed the hypercholesterolemia-mediated effect on proinflammatory T-cell populations specifically in the liver, but not in the spleen. However, WD treatment increases also Treg cell numbers in secondary lymphoid organs 42 (manuscript in preparation). Therefore, it is possible that increased concentrations of TGF-β1 in liver and plasma elicited through hypercholesterolemia may affect T-cell differentiation systemically. However, iTreg cell differentiation in vitro via polyclonal TCR (T-cell antigen receptor) stimulation in the presence of TGF-β1 was unaffected by LDL particles and LDLr deficiency did not impair Treg cell numbers ex vivo. This suggests that the hypercholesterolemia-mediated increased differentiation of intrahepatic iTreg/Th17 cells in vivo acts indirectly through local TGF-β1 induction and APC maturation rather than by intrinsic CD4 + T-cell mechanisms. In line with this, hepatocyte damage and intrahepatic accumulation of CD11b + CD11c
+ cells, a phenotype that has been attributed to infiltrating monocytes that promote Th1 differentiation upon liver injury, 43 coincides in Ldlr −/− mice with the favored differentiation of Th1 over Th17 cells. Th1 cells are known to be hepatocyte-destructive, whereas Th17 cells have been linked to liver homeostasis, are dispensable for liver injury in experimental models, and even protect against Th1-mediated hepatocyte apoptosis. [44] [45] [46] Interestingly, an increased Th1/Th17 cell ratio, as observed in Ldlr −/− mice of our study, is known to be detrimental in atherosclerosis-prone Apoe −/− mice. 47, 48 A recent study by Butcher et al 49 found that Treg cells upon adoptive transfer migrate into the atherosclerotic aorta, where they maintain their FoxP3 expression but undergo Th1-phenotypic changes and lose suppressive capacity. In line with this, our study shows that adoptive transfer of intrahepatically differentiated T cells into atherosclerotic Ldlr −/− mice resulted in a preferential accumulation of transferred T cells in the recipient aorta. Moreover, transferred hepatic T cells that migrated into the aorta were highly differentiated and displayed elevated FoxP3 and ROR-γt expression compared with the resident T-cell population. This T-cell profile corresponds to the intrahepatic T-cell differentiation induced by hypercholesterolemia. Thus, the phenotype of hepatic T cells derived from hypercholesterolemic mice may explain their increased relocation into the aorta, whereas the remigration into the liver was nonspecific for T-cell subsets and unaffected by the treatment of donor mice. The mechanisms governing the selection of homing T cells in the aorta are unknown and may involve local expansion as well as selective recruitment by chemotactic molecules. Our results suggest that intrahepatically differentiated iTreg/Th17 cells affect the ratio of T-cell subsets in the atherosclerotic aorta. However, we cannot rule out the possibility that residential/transferred cells lost their signature cytokine expression because of plasticity, or died at the inflammation site due to exhaustion. Further investigations of intrahepatically differentiated T-cell subsets should elucidate how their migration to atherosclerotic lesions is regulated and to what extent these particular cells control the size and composition of plaques, as it has been reported in studies using global genetic targeting of Th1 and Th17 cells. [50] [51] [52] iTreg and Th17 cell differentiation is influenced by diet and metabolism. In secondary lymphoid organs, this process is influenced by bacterial metabolites of dietary fibres and sodium chloride, respectively. 53, 54 However, WD used in our experiments had no increased fiber or sodium chloride content compared with SCD. Moreover, LDLr deficiency further elevated iTreg cell generation in WD fed mice. Thus, we assume that intrahepatic iTreg/Th17 cell differentiation depends on dietary cholesterol rather than changes of gut microbiota activity or electrolyte homeostasis.
The standard treatment for hypercholesterolemia is the blockade of de novo cholesterol synthesis by inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase through statins. Interestingly, statin treatment increases Treg cell populations in mice and men. 55 However, this effect has not been linked to restoration of lipid metabolism in hepatocytes but rather to direct interaction of statins with T-cell differentiation programs, such as enhanced expression and signaling of TGF-β by T cells and inhibition of signal transducers and activators of transcription 3 and signal transducers and activators of transcription 4 phosphorylation in T cells. [56] [57] [58] In light of our results, this suggests that statin-mediated intracellular effects on TGF-β1 signaling may have a similar outcome as the hypercholesterolemia-mediated intercellular effect in that both mechanisms increase TGF-β1-dependent iTreg differentiation.
In conclusion, we discovered that increasing plasma cholesterol concentrations in WD fed mice correlated linearly with expansion of the intrahepatic CD4 +
FoxP3
+ CD25 low Treg cell population. This T-cell subset expressed significantly less Helios and more Ki-67 in response to WD and was associated with hypercholesterolemia-dependent increased expression of hepatic TGF-β1, indicating a locally induced generation of iTreg cells. In line with this, hypercholesterolemia provoked immunosuppressive conditions in the liver of wild-type mice. However, this hepatic tolerance induction was overcome in severely hypercholesterolemic Ldlr −/− mice, in which hepatocyte damage led to CD11b +
CD11c
+ cell accumulation and Th1 instead of Th17 cell differentiation. Upon adoptive transfer, intrahepatically differentiated Treg cells homed to atherosclerotic lesions, suggesting that they may exert modulating effects on disease development. Therefore, hypercholesterolemia may mobilize atheroprotective immunity by promoting intrahepatic differentiation of Treg cells.
